Smart Nanovirus

Smart Nanovirus is a biotechnology company focused on developing a novel class of antiviral therapeutics designed to mimic human cell surfaces to trap and neutralize viruses. The company's platform utilizes thio-ether lipid-based nanomicelles that act as 'nanodecoys,' binding to viral glycoproteins and preventing the virus from entering host cells. By targeting the conserved binding mechanisms of viruses rather than specific genetic sequences, the technology aims to provide broad-spectrum efficacy and resistance to viral mutations. Their current research pipeline includes candidates for COVID-19, influenza, and various herpesviruses.